Experts hail ‘remarkable’ trial results for treatment of a form of skin cancer that once had grim prognosis
More than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found.
The combined treatment has transformed survival rates for a form of skin cancer that once had a grim prognosis, with some patients now living long enough that they die from other causes.
More Stories
Russian scientist held in Ice jail charged with smuggling frog embryos into US
The Cybertruck was supposed to be apocalypse-proof. Can it even survive a trip to the grocery store?
Trump agrees deal for UAE to build largest AI campus outside US